In vitro fertilization (IVF) and storage of the resulting embryos is currently a proven method of fertility preservation for women who face an immediate threat to their future fertility. This method, however, is suitable for a fraction of patients and depends on a number of factors that may include her diagnosis, age, partner status, willingness to accept donor sperm, desire to freeze embryos, and ability to pay for these services. As fertility preservation techniques evolve, it is critical that physicians continue to evaluate practice guidelines in order to offer a wider menu of fertility preservation options tailored to each patient’s specific clinical scenario, to the risk-benefit ratio and takes into consideration the patient’s values.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005;83:1622–1628.
Practice Committee of the American Society for Reproductive Medicine and the Committee of the Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2006;86:S142–S147.
Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations of fertility preservation in cancer patients. J Clin Oncol 2006;24:2917–2931.
Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;4:209–218.
Robertson JA. Cancer and fertility: ethical and legal challenges. J Natl Cancer Inst Monogr 2005;34:104–106.
Oktay K, Buyuk E, Davis O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003;18:90–95.
Oktay, K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005;23:3858–3859.
Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005;23:4347–4353.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Backhus, L.E., Kondapalli, L.A., Chang, R.J., Coutifaris, C., Kazer, R., Woodruff, T.K. (2007). Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation. In: Woodruff, T.K., Snyder, K.A. (eds) Oncofertility Fertility Preservation for Cancer Survivors. Cancer Treatment and Research, vol 138. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72293-1_17
Download citation
DOI: https://doi.org/10.1007/978-0-387-72293-1_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-72292-4
Online ISBN: 978-0-387-72293-1
eBook Packages: MedicineMedicine (R0)